Tags » Pharma

Namenda Generic Available: Price Plummets!

Great news for those taking Namenda!

“The generic for Namenda is now available in pharmacies. A happy day for the caregivers of persons afflicted with Alzheimer’s and dementia worldwide. 21 more words

Alzheimers

Drug exports to see $1.2bn hit on EU ban

Source: Times of India, Jul 28, 2015

HYDERABAD: The European Commission’s recent decision to ban over 700 generic drugs for alleged manipulation of clinical trials… 225 more words

Business News In India

Four reasons Praluent is not Sovaldi

From the New York Times (New Drug Sharply Lowers Cholesterol, But it’s Costly)

Praluent, which analysts project will become a huge seller, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical prices, and health plans are expected to put in place strict measures to control which patients can use the drug and prevent it from becoming a budget buster. 526 more words

Pharma

Israeli drug firm Teva buys Allergan's generics business for $40 billion

Israel’s Teva Pharmaceuticals Industries Ltd said Monday it’s dropping its hostile bid for Mylan Inc. and hooking up instead with Allergan Inc. .

Tel Aviv-based Teva will buy Allergan’s generics business for $40.5 billion in cash and stock, in a deal that will catapult it into the world’s top 10 pharma companies. 300 more words

International

Compulsory Licensing Application against the Patented Drug SAXAGLIPTIN by Lee Pharma

Lee Pharma, a Hyderabad based Indian pharma company, has filed a Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the patented drug Saxagliptin for treating Diabetes Mellitus. 913 more words

News & Updates

Section 3(D) of Indian Patent Act Strikes Again

India revoked yet another drug patent granted to a German MNC, Boehringer Ingelheim, for its respiratory drug, Spiriva (crystalline tiotropium bromide monohydrate) at a time when the US is putting pressure on Indian government for not providing adequate patent protection to multinational drug companies. 726 more words

News & Updates